标题
NLRP3-mediated Inflammation in CardioOncology: Sterile yet Harmful
作者
关键词
-
出版物
Translational Research
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-08-07
DOI
10.1016/j.trsl.2022.08.004
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination
- (2022) Taejoon Won et al. Frontiers in Immunology
- Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
- (2022) Anja Karlstaedt et al. Nature Reviews Cardiology
- The Role of Anthracyclines in Cardio-Oncology: Oxidative Stress, Inflammation, and Autophagy
- (2022) Leonardo Schirone et al. Oxidative Medicine and Cellular Longevity
- Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway
- (2022) Hui Zhang et al. Journal of Inflammation Research
- Mitochondrial Dynamics in Adult Cardiomyocytes and Heart Diseases
- (2021) Anqi Li et al. Frontiers in Cell and Developmental Biology
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Resveratrol reduces cardiac NLRP3‐inflammasome activation and systemic inflammation to lessen doxorubicin‐induced cardiotoxicity in juvenile mice
- (2021) Zaid H. Maayah et al. FEBS LETTERS
- Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
- (2021) Nathan Mewton et al. CIRCULATION
- Autophagy in major human diseases
- (2021) Daniel J Klionsky et al. EMBO JOURNAL
- Immune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management
- (2021) Seyed Parsa Eftekhar et al. Expert Review of Anticancer Therapy
- The SGLT-2 inhibitor dapagliflozin reduces cell death and apoptosis in cardiomyocytes exposed to trastuzumab and doxorubicin through NLRP3-mediated pathways.
- (2021) Nicola Maurea et al. JOURNAL OF CLINICAL ONCOLOGY
- Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression
- (2021) Vincenzo Quagliariello et al. Frontiers in Oncology
- Gamma Radiation Induce Inflammasome Signaling and Pyroptosis in Microvascular Endothelial Cells
- (2021) Alhaji Osman Smith et al. Journal of Inflammation Research
- An update on the pathophysiology of acute and recurrent pericarditis
- (2021) Aldo BONAVENTURA et al. PANMINERVA MEDICA
- Targeting the NLRP3 inflammasome in cardiovascular diseases
- (2021) Stefano Toldo et al. PHARMACOLOGY & THERAPEUTICS
- Late Ca2+Spark Arrhythmogenesis in Failing Cardiac Myocytes
- (2020) Ewan D. Fowler et al. BIOPHYSICAL JOURNAL
- Rho Kinase Inhibition by Fasudil Attenuates Adriamycin-Induced Chronic Heart Injury
- (2020) Yi Yan et al. Cardiovascular Toxicology
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a Position Statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- (2020) Alexander R. Lyon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Precisely and Efficiently Enzyme Response Microspheres with Immune Removal Escape Loaded with MCC950 Ameliorate Cardiac Dysfunction in Acute Myocardial Infarction
- (2020) Panke Cheng et al. Journal of Biomedical Nanotechnology
- ACUTE EFFECTS OF INTERLEUKIN-1 BLOCKADE USING ANAKINRA IN PATIENTS WITH ACUTE PERICARDITIS
- (2020) George F. Wohlford et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury
- (2020) Sean M. Davidson et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- THE SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR DAPAGLIFLOZIN EXERTS CARDIOPROTECTIVE EFFECTS AGAINST DOXORUBICIN AND TRASTUZUMAB TOXICITY THROUGH TLR4/MYD88/NF-KB SIGNALING AND NLRP3 INFLAMMASOME PATHWAY
- (2020) Nicola Maurea et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- (2020) Joerg Herrmann Nature Reviews Cardiology
- The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury
- (2020) Shanshan Huang et al. Frontiers in Cell and Developmental Biology
- Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity
- (2020) Shanshan Wei et al. Cardiovascular Toxicology
- The Role of Biomarkers in Cardio-Oncology
- (2020) Kajaluxy Ananthan et al. Journal of Cardiovascular Translational Research
- Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial
- (2020) David C. Tong et al. CIRCULATION
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
- (2020) Vincenzo Quagliariello et al. Journal of Personalized Medicine
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
- (2020) Allan L. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
- (2020) Niklas Lonnemann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca 2+ /Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
- (2019) Takeshi Suetomi et al. CIRCULATION
- Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
- (2019) Nicolas Palaskas et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade
- (2019) Tinna Christersdottir et al. EUROPEAN HEART JOURNAL
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
- (2019) Masafumi Takahashi JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- NLRP3 inflammasome in cardioprotective signaling
- (2019) Coert J Zuurbier JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
- (2019) Ying Jin et al. Journal of the American Heart Association
- Drugs to Inhibit the NLRP3 Inflammasome
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
- (2019) Lieselotte Vande Walle et al. PLOS BIOLOGY
- Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3
- (2019) Liping Meng et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors
- (2019) Justin M. Canada et al. AMERICAN JOURNAL OF CARDIOLOGY
- Aging Induces an Nlrp3 Inflammasome-Dependent Expansion of Adipose B Cells That Impairs Metabolic Homeostasis
- (2019) Christina D. Camell et al. Cell Metabolism
- Cardiovascular Toxicity Induced by Kinase Inhibitors: Mechanisms and Preclinical Approaches
- (2019) Sarah D. Lamore et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
- (2018) Chunxia Yao et al. CIRCULATION
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- Anthracycline Cardiotoxicity
- (2018) Daniel Bernstein CIRCULATION RESEARCH
- Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
- (2018) Varun Jain et al. JOURNAL OF IMMUNOTHERAPY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Cardiotoxicity of Cancer Therapies
- (2018) Pratik Mondal et al. Cardiology in Review
- Role of pyroptosis in cardiovascular disease
- (2018) Zeng Zhaolin et al. CELL PROLIFERATION
- Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab
- (2017) Milos Dokmanovic et al. Expert Opinion on Drug Metabolism & Toxicology
- Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
- (2017) Peter A Henriksen HEART
- Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production bothin vitroand in a mouse model of inflammation
- (2017) Mariela Castelblanco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasome and Autophagy Regulation: A Two-way Street
- (2017) Qian Sun et al. MOLECULAR MEDICINE
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Adapting to obesity with adipose tissue inflammation
- (2017) Shannon M. Reilly et al. Nature Reviews Endocrinology
- Acute Myocardial Infarction
- (2017) Jeffrey L. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Pericarditis
- (2017) Niraj S. Doctor et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway
- (2017) Takayuki Kimura et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction
- (2017) Luís E. Pavillard et al. Oncotarget
- Trastuzumab cardiotoxicity: from clinical trials to experimental studies
- (2016) Balazs T Nemeth et al. BRITISH JOURNAL OF PHARMACOLOGY
- HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
- (2016) Damien Bertheloot et al. Cellular & Molecular Immunology
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
- (2016) Antonio Brucato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preventing antiblastic drug-related cardiomyopathy
- (2016) Christian Cadeddu et al. Journal of Cardiovascular Medicine
- Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes
- (2016) Nishant Mohan et al. MOLECULAR CANCER THERAPEUTICS
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity
- (2016) Motoi Kobayashi et al. Scientific Reports
- The Inflammasome in Myocardial Injury and Cardiac Remodeling
- (2015) Stefano Toldo et al. ANTIOXIDANTS & REDOX SIGNALING
- Anti-Inflammatory Treatment With Colchicine in Acute Myocardial InfarctionClinical Perspective
- (2015) Spyridon Deftereos et al. CIRCULATION
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Chemotherapy-induced cardiomyopathy
- (2015) Angela Y. Higgins et al. HEART FAILURE REVIEWS
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Unknown
- (2015) Eleonora Mezzaroma et al. MOLECULAR MEDICINE
- Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter
- (2015) Jing Wang et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Hydrogen sulfide and cardioprotection — Mechanistic insights and clinical translatability
- (2015) Fadi N. Salloum PHARMACOLOGY & THERAPEUTICS
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Targeting Conformational Plasticity of Protein Kinases
- (2014) Michael Tong et al. ACS Chemical Biology
- Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
- (2014) Yan Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and Its Relation to Oxidative Stress
- (2014) Ahmet Dirican et al. ANGIOLOGY
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs
- (2014) John Wong et al. CANCER BIOLOGY & THERAPY
- Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
- (2014) Stefano Toldo et al. CARDIOVASCULAR RESEARCH
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Letter by Mezzaroma, et al Regarding Article, “NLRP3 Inflammasome as a Therapeutic Target in Myocardial Infarction”
- (2014) Eleonora Mezzaroma et al. International Heart Journal
- NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
- (2014) Masafumi Takahashi International Heart Journal
- Formation of the inflammasome in acute myocarditis
- (2014) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
- (2014) Yuya Yoshimoto et al. PLoS One
- Role of NLRP3 (cryopyrin) in acute myocardial infarction
- (2013) Eleonora Mezzaroma et al. CARDIOVASCULAR RESEARCH
- Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
- (2013) Heriberto Lima Jr. et al. CELL CYCLE
- Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
- (2013) Shankar S. Iyer et al. IMMUNITY
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation
- (2013) M. E. Heid et al. JOURNAL OF IMMUNOLOGY
- Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice
- (2013) M. Khair ElZarrad et al. PLoS One
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Regulation of inflammasome signaling
- (2012) Vijay A K Rathinam et al. NATURE IMMUNOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
- (2011) Kristin A. D. Sauter et al. CANCER BIOLOGY & THERAPY
- Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress
- (2011) Xiu-Yu Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- The Sterile Inflammatory Response
- (2010) Kenneth L. Rock et al. Annual Review of Immunology
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease
- (2010) Y. Luan et al. EUROPACE
- Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
- (2010) Jinzhou Zhu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
- (2010) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Somatic gene mutation and human disease other than cancer: An update
- (2010) Robert P. Erickson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Pyroptosis: host cell death and inflammation
- (2009) Tessa Bergsbaken et al. NATURE REVIEWS MICROBIOLOGY
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started